NSG 6001 MIDTERM EXAM 1 – QUESTION AND ANSWERS

NSG 6001 MIDTERM EXAM 1 – QUESTION AND ANSWERSNSG 6001 MIDTERM EXAM 1 – QUESTION AND ANSWERS 1. Question : Your patient is morbidly obese and cannot sit on a bicycle or walk a treadmill. She also has marked and severe emphysema. You need to make an assessment of the risk of significant CAD and your patient’s family says that their relative had their diagnosis based on an ultrasound echocardiography. What facts would influence your decision regarding the family request for echo assessment? Student Answer: Specificity would be increased because of obesity Sensitivity would be reduced because of obesity and lung disease (Sensitivity would be reduced because of obesity and lung disease.) Sensitivity would be increased because of lung disease Specificity would be reduced because of obesity and lung disease 2. Question : Medicaid is mandated to be provided by each state through federal codes. Each state must offer Medicaid exactly as the federal government prescribes. True or false? Student Answer: False (Medicaid is mandated to be provided by each state, however, Mediciad is not required to be delivered by any certain formula. Each state has autonomy to deliver Mediciad services under its own guidelines, provided that each state meets the federal guidelines for Medicaid coverage. ) True 3. Question : By standard criteria, how is a positive stress test defined? Student Answer: Development of a horizontal or down sloping ST-segment depression of 10mm Development of a horizontal or down sloping ST-segment depression of 1mm (A positive stress test is defined as the development of a horizontal or down sloping ST-segment depression of 1mm. ) Upward sloping ST-segment measured at the J point of the QRS Down sloping of the ST-segment at the J point of the QRS 4. Question : Population disease management is a term used to describe: Student Answer: Low prevalence specific diseases High prevalence specific diseases (Population disease management is a term used to describe the high prevalence of specific diseases. ) Low specificity diseases states High specificity disease states